New investment from the ADDF’s Diagnostics Accelerator leads efforts to develop standardization materials for leading diagnostic biomarker: New York Saturday, November 16, 2024, ...
It also means they may be more suitable for certain research studies, like clinical trials to test new treatments, should they wish to take part. New treatments for Alzheimer’s disease have shown ...
AI-driven MRI solution, icobrain aria receives US FDA clearance for safer Alzheimer’s treatment: Boston Saturday, November 16, 2024, 16:00 Hrs [IST] icometrix, a g ...